Sub-10¢ Watch: 10 Stocks That Could Explode — August 29, 2026

Sub-10¢ Watch: 10 Stocks That Could Explode — August 29, 2026

In a market characterized by volatility and opportunity, sub-10¢ stocks often capture the attention of speculative investors. Below is a detailed analysis of 10 stocks currently trading under $0.10 that could see explosive growth in the coming months. Each stock is assessed on volume trends, short interest, technical setups, and potential catalysts.

1. SNDL - Sundial Growers Inc. - **Current Price:** $0.09 - **Sector:** Cannabis - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** High short interest at 15%, creating potential for a short squeeze. - **Catalyst:** Upcoming earnings report could reveal improved financials post-cannabis legalization in various states. - **Technical Setup:** Recently bounced off a support level of $0.08. - **Risk Factors:** Regulatory challenges in the cannabis sector. - **Bull Case Price Target:** $0.15 in 30-60 days. - **Risk Rating:** 🟡 High

2. MVIS - Microvision Inc. - **Current Price:** $0.07 - **Sector:** Technology - **Volume Profile:** Increased volume suggests bullish sentiment. - **Short Interest:** Approximately 20% short interest, indicating potential for a squeeze. - **Catalyst:** Patent approval for new LiDAR technology expected next quarter. - **Technical Setup:** Breaking out of a consolidation pattern. - **Risk Factors:** Competition from larger players in the LiDAR space. - **Bull Case Price Target:** $0.12 in 60-90 days. - **Risk Rating:** 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price:** $0.09 - **Sector:** Health Care - **Volume Profile:** Sustained volume increases indicate accumulation. - **Short Interest:** Short interest stands at around 18%. - **Catalyst:** FDA approval for a new health app could drive growth. - **Technical Setup:** Recently bounced off a support level at $0.08. - **Risk Factors:** Regulatory scrutiny could impact operations. - **Bull Case Price Target:** $0.14 in the next 30-60 days. - **Risk Rating:** 🟡 High

4. ATER - Aterian Inc. - **Current Price:** $0.08 - **Sector:** Consumer Goods - **Volume Profile:** Volume has been steadily increasing. - **Short Interest:** High at 22%, indicating strong potential for a short squeeze. - **Catalyst:** New product launch expected to capture market share. - **Technical Setup:** Recently broke out of a downward trend. - **Risk Factors:** Supply chain issues could impede growth. - **Bull Case Price Target:** $0.12 in 30-45 days. - **Risk Rating:** 🟡 High

5. GTE - Gran Tierra Energy Inc. - **Current Price:** $0.09 - **Sector:** Energy - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** Moderate at 10%. - **Catalyst:** Potential acquisition target due to increasing oil prices. - **Technical Setup:** Testing resistance at $0.10. - **Risk Factors:** Fluctuations in oil prices could affect profitability. - **Bull Case Price Target:** $0.15 in 60-90 days. - **Risk Rating:** 🟢 Moderate

6. SIRC - Solar Integrated Roofing Corp. - **Current Price:** $0.05 - **Sector:** Renewable Energy - **Volume Profile:** Volume is rising, indicating increased interest. - **Short Interest:** Low at 8%, reducing squeeze potential. - **Catalyst:** Government incentives for solar energy could drive growth. - **Technical Setup:** Currently bouncing off a support level at $0.04. - **Risk Factors:** Competitive market landscape. - **Bull Case Price Target:** $0.10 in 30-60 days. - **Risk Rating:** 🟢 Moderate

7. LODE - Comstock Mining Inc. - **Current Price:** $0.09 - **Sector:** Materials - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** 12% short interest. - **Catalyst:** Discovery of new gold reserves could boost stock price. - **Technical Setup:** Recently tested support at $0.08. - **Risk Factors:** Commodity price volatility. - **Bull Case Price Target:** $0.14 in 30-60 days. - **Risk Rating:** 🟡 High

8. EDSA - Edesa Biotech Inc. - **Current Price:** $0.06 - **Sector:** Biotechnology - **Volume Profile:** Volume has been increasing steadily. - **Short Interest:** High at 25%. - **Catalyst:** Upcoming Phase 3 trial results could be pivotal. - **Technical Setup:** Consolidating near support at $0.05. - **Risk Factors:** Clinical trial failures could lead to significant losses. - **Bull Case Price Target:** $0.10 in 60-90 days. - **Risk Rating:** 🔴 Very High

9. XCUR - XCUR Technologies Inc. - **Current Price:** $0.04 - **Sector:** Technology - **Volume Profile:** Increased trading volume indicates interest. - **Short Interest:** Low at 5%. - **Catalyst:** New product innovations set for release. - **Technical Setup:** Testing support at $0.03. - **Risk Factors:** Dependence on technology adoption rates. - **Bull Case Price Target:** $0.08 in 30-45 days. - **Risk Rating:** 🟢 Moderate

10. CBAI - CBA Florida Inc. - **Current Price:** $0.03 - **Sector:** Financial Services - **Volume Profile:** Volume spikes indicate growing interest. - **Short Interest:** Approximately 10%. - **Catalyst:** Potential for market expansion could drive growth. - **Technical Setup:** Recently rebounded from support at $0.02. - **Risk Factors:** Market volatility could impact operations. - **Bull Case Price Target:** $0.06 in 30-60 days. - **Risk Rating:** 🟢 Moderate

Why These Price Ranges Matter Sub-10¢ stocks often have lower market capitalizations, enabling significant price movements with relatively small trading volumes. These stocks generally exhibit higher volatility, which can lead to substantial returns—but also substantial risks. Investors need to be aware that liquidity can be limited, and price swings can be extreme.

How to Trade Them Safely 1. **Position Sizing:** Use a smaller percentage of your portfolio for these high-risk stocks. This mitigates potential losses. 2. **Limit Orders:** Utilize limit orders for entry and exit to avoid market volatility. 3. **Catalyst Timing:** Stay informed about upcoming catalysts that could drive price movements, and be prepared to act quickly.

Catalyst Calendar - **SNDL:** Earnings report on September 15, 2026. - **MVIS:** Patent announcement expected on October 1, 2026. - **CLOV:** FDA decision on health app due September 28, 2026. - **EDSA:** Phase 3 trial results expected on October 15, 2026.

These stocks represent high-risk speculative plays. Always conduct thorough research and manage your risks effectively.

Educational content only. Not financial advice. DYOR.